Risks and benefits of vaccination – a selection of references from CAB Abstracts

Veterinary pharmacovigilance studies the adverse effects of veterinary medicinal products after they have been placed on the market. Information about suspected lack of efficacy, potential environmental risks as well as the validity of the drug withdrawal times are also taken into account. In France, information provided to the national veterinary pharmacovigilance system, which was formally established in 2002, is mainly supplied by spontaneous declaration. According to the 2013 annual report of pharmacovigilance by the National Agency for Veterinary Medicinal Products, 83% and 9% of reports of adverse effects in 2012 relate respectively, to domestic carnivores and cattle. External parasiticides and vaccines are the drug classes most frequently cited in notifications concerning dogs and cats. Despite the effectiveness of the current system, incentives and encouragement are still required in practice to improve the participation of the service notifiers of the proper use and safety of veterinary medicinal products.